Abstract
Introduction
There is clinical uncertainty regarding the optimal method of rehabilitation following flexor tendon repair. Many splint designs and rehabilitation regimens are reported in the literature; however, there is insufficient evidence to support the use of any one regimen. The aim of this study was to describe rehabilitation guidelines used in the United Kingdom (UK) following zone I/II flexor tendon repair.
Methods
Using a cross-sectional design, hand units in the UK were invited to complete a short survey and to upload their flexor tendon rehabilitation guidelines and patient information material. Approval was granted by the British Association of Hand Therapists. Data were extracted in duplicate, using a pre-piloted form, and analysed using descriptive statistics.
Results
Thirty-five hand units responded (21%), providing 52 treatment guidelines. Three splinting regimens were described, and all involved early active mobilisation: (i) long dorsal-blocking splint (DBS); (ii) short DBS; and (iii) relative motion flexion splint. Duration of full-time splint wear ranged from 4 to 6 weeks. There were variations in splint design and composition of home exercise programmes, particularly for the long DBS. Where reported, recommended return to driving ranged from 8 to 12 weeks, and return to light work activities ranged from 5 to 10 weeks.
Discussion
Treatment guidelines varied across UK hand therapy departments, suggesting that patients receive differing advice about how to protect, move and use their hand after zone I/II flexor tendon repair. The disparity in splint wear duration, home exercise frequency and prescribed functional restrictions raises potential financial and social implications for patients. Future research should explore rehabilitation burden in addition to clinical outcomes.
Introduction
Flexor tendon injuries are common1,2 and usually require surgical repair followed by a period of rehabilitation. Clinical uncertainty surrounds many aspects of care including patient information, surgical repair method, splinting, rehabilitation and outcome measurement.3–7 Restoration of movement and function after flexor tendon repair remains a challenge, particularly for zone II injuries.8,9 Rehabilitation must find the balance of protecting the repair site from attenuation or rupture, while also enabling sufficient movement and tendon glide to prevent scar adhesions and joint contractures.
Historically, post-operative flexor tendon rehabilitation involved a long dorsal-blocking splint to immobilise the wrist in neutral or flexion, hold the metacarpophalangeal joints (MCPJs) in flexion and the interphalangeal joints (IPJs) in extension.10–12 This was coupled with active finger extension and passive flexion, achieved with10,11 or without 12 elastic bands. As surgical techniques have progressed, early active mobilisation strategies have become popular. 13 These regimens allow both active and passive extension of the fingers within the splint and are considered to be associated with improved range of movement when compared with the previous passive regimens.8,14,15 Initially these regimens also involved a long dorsal-blocking splint, but more recent advances include a hand-based dorsal-blocking splint16,17 and a finger-based relative motion flexion splint.18,19
Flexor tendon rehabilitation protocols have been published in peer reviewed journals,16,20 but there is currently no robust evidence to support the use of any particular early active rehabilitation regimen, 4 and anecdotally practice varies. The aim of this study was to describe rehabilitation guidelines being used in United Kingdom (UK) hand therapy departments for the management of adult patients following zone I and/or II flexor tendon repairs. Specifically, to review: the indications for treatment; when hand therapy begins; the type of splint and exercise programme; and recommendations for hand function and return to work and driving.
Methods
The steering group developed a protocol for this cross-sectional study, which was published a priori. 21 The study was exempt from formal ethics approval following guidance from the NHS Health Research Authority/Medical Research Council tool 22 (Supplementary file 1).
A short survey was developed by the steering group and refined following feedback from the British Association of Hand Therapists (BAHT) Clinical Evidence Committee as part of their peer review process, and two hand centres. The survey (Supplementary file 2) requested department name, location, composition of the hand surgery and hand therapy teams, and the clinical disciplines responsible for developing departmental flexor tendon rehabilitation guidelines. Respondents were asked to upload relevant flexor tendon treatment guidelines and patient information sheets from their institution. Additional questions related to future research areas within flexor tendon rehabilitation and are not reported as part of this study. The study information explained that only one response was required per department, but that this could be completed by therapists at any level in discussion with their team.
Study data were collected and managed using REDCap electronic data capture tools hosted at the Kennedy Institute of Rheumatology.23,24 REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support data capture for research studies, providing (i) an intuitive interface for validated data capture; (ii) audit trails for tracking data manipulation and export procedures; (iii) automated export procedures for seamless data downloads to common statistical packages; and (iv) procedures for data integration and interoperability with external sources.
With the required approvals, the survey was advertised by BAHT, the British Society for Surgery of the Hand and the Reconstructive Surgical Trials Network (RSTN) using e-bulletins, social media and website posts. Data collection occurred between September 2020 and February 2021.
Data from the uploaded treatment guidelines were independently extracted in duplicate by LN and one of JL, DH and MG, using a pre-piloted form. Extracted data included: treatment timescales, splint type and duration of wear, indications for use, exercise programmes and recommended timescales for return to driving and different functional or occupational activities. Piloting involved independent data extraction of the first three responses by LN, JL and DH followed by discussion and modification of the form to facilitate standardised use. In the case of any discrepancies, the documents were reassessed, and the final data entry agreed by two members of the study team. Data were summarised using descriptive statistics. Time periods were reported using the median and range, with the mode also reported if this differed from the median. Where an individual treatment guideline advised a range of time points, this was recorded using the mean, for example, 5–6 weeks was recorded as 5.5 weeks.
Results
Participants
Characteristics of participating hand therapy departments.
Indications for treatment
Indications, considerations and contraindication for use of each splinting regimen.
Rehabilitation timescales
Most guidelines outlined when hand therapy should commence after surgery (n = 46, 88%). This information was frequently presented as a range of suitable time points. The earliest timepoint was a median of 3 days (range 1–5) and the latest was a median of 5 days (range 3–7).
Recommended joint positions with different splint designs
Recommended wrist and metacarpophalangeal joint position within the splint.
areported as 0–15°.

Examples of the three splint designs described in the flexor tendon rehabilitation guidelines.
Duration of splint wear
For the long DBS, the median recommended duration of full-time splint wear was 5.75 weeks (range 4–6, mode 6), compared with 6 weeks (range 5–6) for the short DBS (n = 14). The single RMF splint guideline advised 5–6 weeks of splinting, with the wrist component weaned from week four. Thirty-five patient information sheets (79.5% from a total of 44 provided) specifically stated that the patient should not remove their splint at all during the period of full-time splint wear.
Exercise programmes during full-time splint wear
All treatment guidelines included an exercise programme for the patient to perform at home which incorporated elements of passive and active finger flexion and active extension within the confines of the splint. Active flexion exercises were described in two forms, controlled active movement (flexion within a prescribed range that increased each week [n = 25, 48%]) and flexion as able (n = 27, 52%). Tenodesis (active wrist flexion with relaxed finger extension moving to active wrist extension with relaxed finger flexion) was included in all exercise guidelines for the short DBS (n = 14) from the first appointment. More than half of the long DBS guidelines also included tenodesis exercises (n = 20, 54%); the median recommended time to start tenodesis was 3 weeks after surgery (range 1–6).
Daily hand and wrist exercise duration for the first week of rehabilitation.
aBased on the assumption that a single exercise repetition takes 5 s with 12 h of available exercise time per day. Where exercises were specified to be performed separately for each finger, this was calculated in total for four digits. Where a range of repetitions was provided, the mean was use for this calculation. Only hand/wrist exercises were included.
Hand function and return to work and driving
Recommended timescales for return to work and driving after zone I/II flexor tendon repair.
aMode 8 weeks.
Discussion
We collected >50 different treatment guidelines for adults undergoing zone I/II flexor tendon repair from 35 hand therapy departments. The prevailing view in the literature is that early active mobilisation is associated with improved outcomes in comparison with passive mobilisation, 4 and this was reflected in our data: all departments provided guidelines that followed early active mobilisation principles. In addition, one department included a ‘modified Duran protocol’ that advised passive finger flexion exercises for the first 4 weeks. 12 This was specifically indicated for use with tight or vulnerable repairs, and it is possible that other departments might also modify their rehabilitation approach in this situation, although this was not specifically reported.
The recommended timing of hand therapy after surgical repair was largely consistent across sites, and matched the BSSH standard of 3–5 days after surgery. 25 All sites used the traditional long DBS and more than a third of sites had also adopted the hand-based short DBS, first described as a case series in 2014. 17 There is an ongoing randomised controlled trial comparing short and long DBS, but this has yet to be reported. 26 Only one site provided a treatment guideline for the relative motion flexion splint, which was reported as a case series in 2019.18,19 This apparent gradual introduction of new treatment strategies follows the pattern described by the Adoption and Diffusion of Innovations Theory. 27 This theory highlights the importance of early adopters sharing and communicating the benefits of the innovation to facilitate widespread uptake, and it is anticipated that this process will lead to further adoption of the newer splint designs in future. However, caution is required to ensure that innovation is not introduced without proper evaluation. 28
Splint positions varied, particularly for the long DBS, which is consistent with the variation reported in the literature.20,29 Historically, splint designs have progressed from more flexed wrist and MCPJ positions to a more open posture. It has been demonstrated that the force required for IPJ flexion is reduced with wrist extension and MCPJ flexion, albeit in healthy volunteers and cadaver models.30,31 How well these biomechanical models translate to an injured hand remains unknown.
Splint designs for the short DBS largely followed the description provided by Peck et al. in their original summary. 17 However, three sites reduced the wrist extension block from 45 to 40° and increased MCPJ flexion from 30 to 50–90°. This modification may result in less tension through the repaired tendon(s) but could also lead to reduced differential glide between FDP and FDS. Again, whether this difference in splint design translates to any meaningful clinical difference is unknown.
The RMF splint design also differed from the published case series. Henry and Howell describe 30–40° relative flexion of the injured finger MCPJ, 18 compared with 20° in the identified treatment guideline. RMF splinting uses the quadriga effect to offload the FDP tendon for the digits held in relatively more MCPJ flexion, 32 but the optimal, and practically achievable, amount of relative flexion is unclear.
Future advances in flexor tendon rehabilitation may dispense with full-time splint use altogether. Henry et al. reported a retrospective case series of 51 flexor tendon patients when a splint was used ‘as a defensive shield only in particularly dangerous environments (p407)’ 33 . The splint was positioned in wrist extension and MCPJ flexion, although joint angles were not reported. Splints were included in all guidelines identified for the current study and the duration of full-time wear ranged from 4 to 6 weeks. Although full-time splint wear was recommended, this may not reflect actual practice. A survey of 80 patients who underwent flexor or extensor tendon repair in the UK found that 67% of patients reported removing their splints, most commonly for washing and dressing. 34 Reduction in splint use may benefit patients’ return to work and activities of daily living and is a key area for future research.
Reported exercise programmes showed consistency in the main movement patterns (active and passive finger flexion and active finger extension), but the number of repetitions and frequency varied enormously. The available range of motion also differed depending on the splint position, as discussed above. None of the guidelines advocated full active composite extension of the MCPJs and IPJs within the first 4 weeks of surgery, as prescribed in the study by Henry et al. 33 Across the identified guidelines, the greatest range of finger movement was available with the RMF splint and short DBS.
The short DBS guidelines all included tenodesis exercises (synergistic wrist and finger movement) from the first appointment, as recommended by Peck et al. 17 It was interesting that approximately half of the long DBS regimens also incorporated tenodesis exercises, as an apparent modification of the original long DBS early active mobilisation regimen. 13 A specific tenodesis splint has also been reported in the management of flexor tendon repairs, 29 but this was not included in any identified guidelines. Tenodesis has been associated with increased tendon gliding in comparison with isolated movement 35 and may be beneficial in reducing tendon adhesion following flexor tendon repair. 36 The optimal timing and format of introducing tenodesis exercises is unknown.
Approximately half of the treatment guidelines described controlled active movement (active finger flexion within a prescribed range that increased each week during full-time splint wear), while the remaining half advised active flexion to whatever the patient could achieve. The current BSSH guidelines advocate controlled active motion regimens, 25 as does the original short DBS description. 17 The reasoning for controlled active movement exercises are that this reduces the tension at the repair site, while still achieving sufficient tendon glide; however, there is no evidence that either exercise strategy is superior to the other in practice. 4
We took the approach of calculating exercise time as a measure of patient burden to enable comparison of the different exercise regimens. This did not include the time spent performing scar massage as this was very rarely quantified. We used the assumption that a single exercise repetition takes 5 s and that there were 12 h of available exercise time per day. Given that this will vary, different patients may accumulate substantially different total rehabilitation times. Our assumptions were discussed with practising hand therapists for face validity, but we welcome further conversation on the assessment of the time burden of hand therapy home exercise programmes. The amount of time that patients were expected to engage in daily exercises ranged from several minutes to an hour and half. The ideal exercise dose for optimal clinical outcomes is unclear. A recent opinion piece by a prominent hand surgeon suggested that 40–80 cycles of active flexion were needed in each exercise session, with the number of consecutive repetitions more important than the number of sessions per day. 20 However, this recommendation was based on personal opinion, rather that robust research evidence. The duration of the exercise programme has obvious implications for the patient in terms of work and other activities that they need to engage with during the day. It is also unclear whether the amount of exercise prescribed after flexor tendon repair, or the format of exercise delivery (paper, website, mobile phone application) affects adherence. 37
Advice regarding return to work and function was poorly reported in the guidelines. Two of the splint designs (RMF and short DBS) allowed hand function within the splint, advocating light function with the unaffected fingers only. This is similar to the advice reported in the literature.17–19 Interestingly, more than a third of the short DBS guidelines did not permit any hand function, despite this being a key feature of the splint design. 17
Where reported, return to light work was recommended at a median (and mode) of 8 weeks after surgery and return to heavy manual work at 12 weeks, for all splint types. There is limited evidence to support these timescales. 4 We were surprised to find that the median recommended time for patients to return to driving was longer for the DBS and RMF flexion splints, as these regimens are purported to facilitate faster return to functional hand use.17,18
Limitations
Participants in this study were a self-selected sample of hand therapy departments and we acknowledge that our findings may not be representative of all settings. We took steps to capture a range of views by advertising the study though three relevant organisations (BAHT, BSSH and RSTN) and via social media and websites, in addition to email bulletins. We recruited 35 sites with widespread geographical representation and different combinations of surgical and therapy disciplines. Our estimation is that this represents 21% of UK hand units. We chose to include the response from Ireland; although this is outside the UK, the organisation of hand surgery and hand therapy is similar. It is a limitation that we had not planned to specially include, or advertise the study with, the Irish Association of Hand Therapists.
We also acknowledge that treatment guidelines may not be a true reflection of the treatment provided in practice. Treatment may need to be modified to meet the needs of individual patients, or practice may have changed without the guidelines being updated. However, we believe this is a useful method of capturing ‘routine’ practice.
Conclusions
Treatment guidelines varied across UK hand therapy departments. The short DBS regimen does not appear to be universally adopted and there was only one guideline submitted for a RMF splint regimen. The optimal rehabilitation programme following zone I/II flexor tendon repairs is unclear and this study both highlights the need for consensus and provides a starting point for this discussion. The disparity in splint wear duration, home exercise frequency and prescribed functional restrictions raises potential financial and social implications for patients, particularly in relation to return to work and driving. Future research should explore rehabilitation burden in addition to clinical outcomes.
Footnotes
Acknowledgements
Thank you to all participating hand therapy departments. We appreciate your willingness to share your treatment guides for this review: Vicky Buchan, NHS Grampian (Woodend Hospital); Nick Gape, Cardiff and Vale University Health Board; Hayley Fay, Chelsea and Westminster Hospital NHS Foundation Trust; Hayley McGurk, Chesterfield Royal Hospital NHS Foundation Trust; Cassandra Harkness, NHS Greater Glasgow and Clyde (Glasgow Royal Infirmary); Rachel O’Riordan, Guy’s and St Thomas’ NHS Foundation Trust and Barts Health NHS Trust; Kevin Spear, Hampshire Hospitals NHS Foundation Trust; Dorothy Gilchrist, Hull University Teaching Hospitals NHS Trust (Castle Hill Hospital); Darren Laughland, Imperial College Healthcare NHS Trust; Leanne Topcuoglu, Lancashire Teaching Hospitals NHS Foundation Trust; Suzanne Oxley, Leeds Teaching Hospitals NHS Trust; NHS Frimley Health Foundation Trust (Wexham Park Hospital); Caroline Scarrow, Sheffield Teaching Hospitals NHS Trust; Justine Bullock, Nottingham University Hospitals NHS Trust; Rhian Hughes, Swansea Bay University Health Board (Morriston Hospital); Gemma Willis, Portsmouth Hospital University NHS Trust; Matt Allen, Royal Cornwall Hospitals NHS Trust; Emma Bamford, University Hospitals of Derby and Burton (Pulvertaft Hand Centre); Suzannah Blake, Royal Devon and Exeter NHS Foundation Trust; Nikki Burr, Royal Free London NHS Foundation Trust; Emma Patterson, Northern Care Alliance NHS Trust (Oldham Care Organisation, The Royal Oldham Hospital); Stuart Watson, Newcastle upon Tyne Hospitals NHS Foundation Trust; Simi Padmanabhan, Salisbury District Hospital NHS Foundation Trust and University Hospital Southampton NHS Foundation Trust; Nicole Lyons, South Tees NHS Foundation Trust; Sarah Griffiths, St Helens and Knowsley Teaching Hospitals NHS Trust (Whiston Hospital); Emma Carr, St Vincent’s University Hospital; Maeve McConnell, South Eastern Health and Social Care Trust; Suzanne Beale, University Hospitals Birmingham NHS Foundation Trust (Queen Elizabeth Hospital); Catherine Rolls, University Hospitals Bristol and Weston NHS Foundation Trust; Lynne Nicholls, University Hospitals Coventry and Warwickshire NHS Trust; Tracy Graham, University Hospitals of Leicester NHS Trust; Fleur Nicholas, University Hospitals Plymouth NHS Trust; Simi Padmanabhan, University Hospital Southampton; and An van Hyfte, Worcester Acute Hospitals NHS Trust. Thank you also to Emma Reay for supporting data analysis and BAHT Clinical Evidence Committee for appraising the survey and providing helpful comments for improvement.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Ethical approval
The study was exempt from formal ethics approval following guidance from the NHS Health Research Authority/Medical Research Council tool (Supplementary file 1).
Informed consent
The purpose of the survey and links to the protocol were provided at the start of the survey. Respondents were asked to opt in to participate.
Guarantor
LN.
Contributorship
All authors conceived the study and developed the protocol and survey. LN extracted all data with duplicate data entry by one of JL, MG and DH. LN, JL and DH analysed the data with review by all authors. LN wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version.
